Olivier Breyne

This inventor holds 22 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Corning S.a., Flamel Technologies, Corning Incorporated. Active years: 2001-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olivier Breyne. Retrieved from https://idiyas.com/inventor/olivier-breyne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 3)

% Patents Active = 68.2

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 2.6

ph-index = 9

Forward Citations = 199(Granted Patents)

Location History:

Borneil-sur-marne, FR (2002)
Lyons, FR (2001 - 2018)

Company Filing History:

Flamel Ireland Limited

patents

6. 1 out of 834,570

Other

patents

Years Active: 2001-2018

Loading Chart...

Areas of Expertise:

Active Agent

Polyglutamic Acids

Modified-Release

Therapeutic Applications

Polyelectrolytes

Photochromic Compounds

Hydrophobic Groups

Polyamino Acids

Naphthopyrans

Composition

Polymer Matrices

Indole

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10052289 - Composition comprising an active agent with low aqueous solubility (2018-08-21),

2. 8716217 - Polyglutamic acids functionalized by cationic groups and hydrophobic groups and applications thereof, in particular therapeutic applications thereof (2014-05-06),

3. 8481019 - Modified-release particles of polyelectrolytes and pharmaceutical formulations thereof (2013-07-09),

4. 8293255 - Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof, in particular for therapeutic purposes (2012-10-23),

5. 8236353 - Self-precipitating pharmaceutical formulations for the modified release of an active principle (2012-08-07),

6. 7919572 - Polyamino acids functionalised with at least one hydrophobic group and applications thereof particularly therapeutic applications (2011-04-05),

7. 7683024 - Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications (2010-03-23),

8. 7678882 - Polyamino acids functionalized by at least one hydrophobic group and the therapeutic application thereof (2010-03-16),

9. 7659365 - Telechelic homopolyamino acids functionalized with hydrophobic groups, and their applications, especially therapeutic applications (2010-02-09),

10. 7332260 - Naphthopyrans annelated in C5-C6, their preparation and compositions and (CO)polymer matrices containing them (2008-02-19),

11. 7250120 - Benzo-, naphtho- and phenanthrochromene substituted by carbamated or ureated phenyls, preparation thereof and compositions and articles containing them (2007-07-31),

12. 6719925 - Naphthopyrans with a heterocycle in the 5, 6-position, preparation, and (co)polymer compositions and matrices containing them (2004-04-13),

13. 6558583 - Naphthopyrans annelated in C5-C6 with a dihydrobenzo-cycloheptatriene-type carbocycle and compositions and matrices containing them (2003-05-06),

14. 6506538 - Naphthopyrans annelated in C5-C6, their preparation and compositions and (co)polymer matrices containing them (2003-01-14),

15. 6506322 - Naphthopyrans annelated in C5-C6 with an indene- or dihydronaphthalene-type carbocycle, and compositions and (co)polymer matrices containing them (2003-01-14),

Title: Olivier Breyne: Innovator in Biodegradable Materials and Therapeutic Applications

Introduction

Olivier Breyne, located in Lyons, France, is a prolific inventor with 22 patents to his name. His work primarily focuses on compositions enhancing the solubilization of active ingredients, particularly in the pharmaceutical and cosmetic fields. Breyne's innovations have significantly impacted the development of biodegradable materials that facilitate the effective delivery of active principles.

Latest Patents

Among Olivier Breyne's latest patents is a composition that comprises an active agent with low aqueous solubility. This invention emphasizes the association of the active ingredient with nanoparticles formed by a specific POM polymer. By achieving a minimum concentration of 5 μmol/g of POM, this invention seeks to improve the aqueous solubilization of low solubility active agents.

Another noteworthy patent involves polyglutamic acids that are functionalized by cationic and hydrophobic groups. This innovation outlines novel biodegradable materials based on modified polyamino acids, which are especially beneficial for the delivery of active principles. The patented method allows for the creation of polymeric materials that meet essential criteria such as biocompatibility, biodegradability, and effective association and release of active principles in vivo.

Career Highlights

Breyne has worked with recognized companies such as Corning S.A. and Flamel Technologies, where he has contributed his expertise in developing innovative solutions in pharmaceuticals and biologically active materials. His work at these companies has played a crucial role in advancing technologies related to drug delivery and active principle vectorization.

Collaborations

Throughout his career, Olivier Breyne has collaborated with distinguished colleagues, including You-Ping Chan and Patrick Jean. These collaborations have fostered a dynamic exchange of ideas, leading to groundbreaking advancements in the field of biodegradable materials and therapeutic applications.

Conclusion

Olivier Breyne stands out as a leading inventor in the realm of biodegradable materials and therapeutic innovations. With a significant portfolio of patents reflecting his dedication to enhancing active ingredient solubilization and vectorization, Breyne continues to contribute profoundly to the fields of pharmaceuticals and biotechnology. His work not only exemplifies the potential of innovative thinking but also holds promise for future advancements in drug delivery systems.

Profile summary based on public USPTO records.